vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Travel & Leisure Co. (TNL). Click either name above to swap in a different company.

Travel & Leisure Co. is the larger business by last-quarter revenue ($961.0M vs $487.7M, roughly 2.0× CLOVER HEALTH INVESTMENTS, CORP.). Travel & Leisure Co. runs the higher net margin — 8.2% vs -10.1%, a 18.3% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 2.9%). Travel & Leisure Co. produced more free cash flow last quarter ($0 vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -1.2%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Travel + Leisure Co. is an American timeshare company headquartered in Orlando, Florida. It develops, sells, and manages timeshare properties under several vacation ownership clubs, including Club Wyndham, WorldMark by Wyndham, Margaritaville Vacation Club, and Accor Vacation Club. The company provides timeshare exchange services, primarily through RCI, and travel clubs including Travel + Leisure GO.

CLOV vs TNL — Head-to-Head

Bigger by revenue
TNL
TNL
2.0× larger
TNL
$961.0M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+41.8% gap
CLOV
44.7%
2.9%
TNL
Higher net margin
TNL
TNL
18.3% more per $
TNL
8.2%
-10.1%
CLOV
More free cash flow
TNL
TNL
$69.0M more FCF
TNL
$0
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-1.2%
TNL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLOV
CLOV
TNL
TNL
Revenue
$487.7M
$961.0M
Net Profit
$-49.3M
$79.0M
Gross Margin
Operating Margin
-10.1%
16.5%
Net Margin
-10.1%
8.2%
Revenue YoY
44.7%
2.9%
Net Profit YoY
-123.2%
8.2%
EPS (diluted)
$1.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
TNL
TNL
Q1 26
$961.0M
Q4 25
$487.7M
$1.0B
Q3 25
$496.6M
$1.0B
Q2 25
$477.6M
$1.0B
Q1 25
$462.3M
$934.0M
Q4 24
$337.0M
$970.0M
Q3 24
$331.0M
$993.0M
Q2 24
$356.3M
$985.0M
Net Profit
CLOV
CLOV
TNL
TNL
Q1 26
$79.0M
Q4 25
$-49.3M
$-62.0M
Q3 25
$-24.4M
$111.0M
Q2 25
$-10.6M
$108.0M
Q1 25
$-1.3M
$73.0M
Q4 24
$-22.1M
$119.0M
Q3 24
$-9.2M
$97.0M
Q2 24
$7.4M
$129.0M
Gross Margin
CLOV
CLOV
TNL
TNL
Q1 26
Q4 25
78.9%
Q3 25
98.8%
Q2 25
97.9%
Q1 25
97.5%
Q4 24
99.0%
Q3 24
24.5%
97.3%
Q2 24
30.3%
97.9%
Operating Margin
CLOV
CLOV
TNL
TNL
Q1 26
16.5%
Q4 25
-10.1%
-2.2%
Q3 25
-4.9%
20.5%
Q2 25
-2.2%
20.2%
Q1 25
-0.3%
16.7%
Q4 24
-6.4%
21.1%
Q3 24
-2.7%
19.0%
Q2 24
2.0%
19.2%
Net Margin
CLOV
CLOV
TNL
TNL
Q1 26
8.2%
Q4 25
-10.1%
-6.0%
Q3 25
-4.9%
10.6%
Q2 25
-2.2%
10.6%
Q1 25
-0.3%
7.8%
Q4 24
-6.6%
12.3%
Q3 24
-2.8%
9.8%
Q2 24
2.1%
13.1%
EPS (diluted)
CLOV
CLOV
TNL
TNL
Q1 26
$1.22
Q4 25
$-0.92
Q3 25
$1.67
Q2 25
$1.62
Q1 25
$1.07
Q4 24
$1.70
Q3 24
$1.39
Q2 24
$1.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
TNL
TNL
Cash + ST InvestmentsLiquidity on hand
$78.3M
$254.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
Total Assets
$541.0M
$6.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
TNL
TNL
Q1 26
$254.0M
Q4 25
$78.3M
$271.0M
Q3 25
$240.0M
Q2 25
$212.0M
Q1 25
$188.0M
Q4 24
$194.5M
$185.0M
Q3 24
$288.0M
$194.0M
Q2 24
$254.8M
$166.0M
Total Debt
CLOV
CLOV
TNL
TNL
Q1 26
Q4 25
$5.6B
Q3 25
$5.6B
Q2 25
$5.6B
Q1 25
$5.7B
Q4 24
$5.6B
Q3 24
$5.6B
Q2 24
$5.6B
Stockholders' Equity
CLOV
CLOV
TNL
TNL
Q1 26
Q4 25
$308.7M
$-981.0M
Q3 25
$340.9M
$-821.0M
Q2 25
$344.2M
$-852.0M
Q1 25
$336.1M
$-903.0M
Q4 24
$341.1M
$-881.0M
Q3 24
$342.2M
$-862.0M
Q2 24
$324.9M
$-885.0M
Total Assets
CLOV
CLOV
TNL
TNL
Q1 26
$6.8B
Q4 25
$541.0M
$6.8B
Q3 25
$559.7M
$6.9B
Q2 25
$575.0M
$6.8B
Q1 25
$583.7M
$6.8B
Q4 24
$580.7M
$6.7B
Q3 24
$653.0M
$6.7B
Q2 24
$674.2M
$6.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
TNL
TNL
Operating Cash FlowLast quarter
$-66.9M
$38.0M
Free Cash FlowOCF − Capex
$-69.0M
$0
FCF MarginFCF / Revenue
-14.1%
0.0%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
0.48×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$423.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
TNL
TNL
Q1 26
$38.0M
Q4 25
$-66.9M
$124.0M
Q3 25
$12.1M
$163.0M
Q2 25
$5.4M
$232.0M
Q1 25
$-16.3M
$121.0M
Q4 24
$34.8M
$98.0M
Q3 24
$50.0M
$145.0M
Q2 24
$44.8M
$174.0M
Free Cash Flow
CLOV
CLOV
TNL
TNL
Q1 26
$0
Q4 25
$-69.0M
$92.0M
Q3 25
$11.4M
$136.0M
Q2 25
$4.8M
$195.0M
Q1 25
$-16.5M
$100.0M
Q4 24
$33.3M
$75.0M
Q3 24
$49.6M
$125.0M
Q2 24
$44.4M
$153.0M
FCF Margin
CLOV
CLOV
TNL
TNL
Q1 26
0.0%
Q4 25
-14.1%
9.0%
Q3 25
2.3%
13.0%
Q2 25
1.0%
19.2%
Q1 25
-3.6%
10.7%
Q4 24
9.9%
7.7%
Q3 24
15.0%
12.6%
Q2 24
12.5%
15.5%
Capex Intensity
CLOV
CLOV
TNL
TNL
Q1 26
Q4 25
0.4%
3.1%
Q3 25
0.1%
2.6%
Q2 25
0.1%
3.6%
Q1 25
0.0%
2.2%
Q4 24
0.5%
2.4%
Q3 24
0.1%
2.0%
Q2 24
0.1%
2.1%
Cash Conversion
CLOV
CLOV
TNL
TNL
Q1 26
0.48×
Q4 25
Q3 25
1.47×
Q2 25
2.15×
Q1 25
1.66×
Q4 24
0.82×
Q3 24
1.49×
Q2 24
6.04×
1.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

TNL
TNL

Other$452.0M47%
Service and membership fees$396.0M41%
Consumer financing$113.0M12%

Related Comparisons